Skip to content

Drug interactions

Lapatinib + Olodaterol inhaled

Severity: Moderate

Lapatinib and Olodaterol inhaled: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib can prolong the QT interval, and beta2-agonists such as olodaterol can cause tachycardia, hypokalemia and QT effects. Together they may modestly increase the risk of arrhythmia, although inhaled systemic exposure is low.

What this interaction means in plain words

Lapatinib and Olodaterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive pharmacodynamic effects on cardiac repolarization and beta2-mediated hypokalemia.

What to do

Monitor ECG and keep potassium and magnesium within normal range, particularly in patients with cardiac disease or other QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Olodaterol inhaled, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Olodaterol inhaled?

MediHelp rates the interaction as moderate. Lapatinib and Olodaterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib can prolong the QT interval, and beta2-agonists such as olodaterol can cause tachycardia, hypokalemia and QT effects. Together they may modestly increase the risk of arrhythmia, although inhaled systemic exposure is low.

How serious is the interaction between Lapatinib and Olodaterol inhaled?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and keep potassium and magnesium within normal range, particularly in patients with cardiac disease or other QT-prolonging drugs.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in